MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL)

Pediatric Blood and Cancer

Volumn 59, Issue 4, 2012, Pages 599-604

  de Oliveira, Jaqueline C ^a   Brassesco, María Sol ^a   Scrideli, Carlos Alberto ^a   Tone, Luiz Gonzaga ^a   Narendran, Aru ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

ALL; Childhood acute lymphoblastic leukemia; Markers; MicroRNA

Indexed keywords

ASPARAGINASE; CYTOKINE; DAUNORUBICIN; MICRORNA; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; B LYMPHOCYTE; BONE MARROW CELL; CANCER PROGNOSIS; CANCER RESISTANCE; DISEASE FREE SURVIVAL; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; HUMAN; LEUKEMIA CELL; LEUKEMOGENESIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; CHILD; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 84864949158     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24167     Document Type: Review

References (52)

1. Pui CH. Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 2010; 109: 777-787.
2. Hunger SP, Raetz EA, Loh ML, et al. Improving outcomes for high-risk ALL: Translating new discoveries into clinical care. Pediatr Blood Cancer 2011; 56: 984-993.
3. Carroll WL, Raetz EA. Clinical and laboratory biology of childhood acute lymphoblastic leukemia. J Pediatr 2011; 160: 10-18.
4. Szczepanek J, Styczynski J, Haus O, et al. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses. Arch Immunol Ther Exp 2011; 59: 61-68.
5. Beesley AH, Cummings AJ, Freitas JR, et al. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: Implications for mechanisms of therapy failure. Br J Haematol 2005; 131: 447-456.
6. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143.
7. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
8. Beezhold KJ, Castranova V, Chen F. Microprocessor of microRNAs: Regulation and potential for therapeutic intervention. Mol Cancer 2010; 9: 134.
9. Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl Res 2011; 157: 216-225.
10. Feng S, Cong S, Zhang X, et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 2011; 39: 6669-6678.
11. Cocco C, Airoldi I. Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia. Cytokine Growth Factor Rev 2011; 22: 149-156.
12. Zanette DL, Rivadavia F, Molfetta GA, et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 2007; 40: 1435-1440.
13. Mi S, Lu J, Sun M, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 2007; 104: 19971-19976.
14. Ju X, Li D, Shi Q, et al. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatr Hematol Oncol 2009; 26: 1-10.
15. Schotte D, Chau JC, Sylvester G, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 2009; 23: 313-322.
16. Oliveira JC, Scrideli CA, Brassesco MS, et al. Differential MiRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. Leuk Res 2011; 36: 293-298.
17. Schotte D, De Menezes RX, Moqadam FA, et al. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica 2011; 96: 703-711.
18. Zhang H, Luo XQ, Zhang P, et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE 2009; 4: e7826.
19. Tanaka M, Oikawa K, Takanashi M, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 2009; 4: e5532.
20. Ohyashiki JH, Umezu T, Kobayashi C, et al. Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: In vivo assessment of cell to plasma ratio of miR-92a. BMC Res Notes 2010; 3: 347.
21. Schotte D, Moqadam FA, Lange-Turenhout EA, et al. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 2011; 25: 1389-1399.
22. Fulci V, Colombo T, Chiaretti S, et al. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer 2009; 48: 1069-1082.
23. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008; 13: 496-506.
24. Xu L, Liang YN, Luo XQ, et al. Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi 2011; 32: 178-181.
25. Kotani A, Ha D, Hsieh J, et al. miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood 2009; 114: 4169-4178.
26. Kaddar T, Chien WW, Bertrand Y, et al. Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation. Leuk Res 2009; 33: 1217-1223.
27. Han BW, Feng DD, Li ZG, et al. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Hum Mol Genet 2011; 20: 4903-4915.
28. Wang Y, Li Z, He C, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis 2010; 44: 191-197.
29. Rodriguez-Otero P, Román-Gómez J, Vilas-Zornoza A, et al. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Br J Haematol 2011; 155: 73-83.
30. Agirre X, Vilas-Zornoza A, Jimenez-Velasco A, et al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 2009; 69: 4443-4453.
31. Sonoki T, Iwanaga E, Mitsuya H, et al. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia 2005; 19: 2009-2010.
32. Bousquet M, Quelen C, Rosati R, et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008; 205: 2499-2506.
33. Bousquet M, Harris MH, Zhou B, et al. MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107: 21558-21563.
34. Gefen N, Binder V, Zaliova M, et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 2010; 24: 89-96.
35. Bhatia S, Kaul D, Varma N. Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia. Mol Cell Biochem 2010; 340: 97-106.
36. Bhatia S, Kaul D, Varma N. Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia. Mol Cell Biochem 2011; 346: 103-116.
37. Schotte D, Lange-Turenhout EA, Stumpel DJ, et al. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica 2010; 95: 1675-1682.
38. Diakos C, Zhong S, Xiao Y, et al. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Blood 2010; 116: 4885-4893.
39. Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9: 405-414.
40. Mavrakis KJ, Wolfe AL, Oricchio E, et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2010; 12: 372-379.
41. Ortholan C, Puissegur MP, Ilie M, et al. MicroRNAs and lung cancer: New oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem 2009; 16: 1047-1061.
42. Li X, Sanda T, Look AT, et al. Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J Exp Med 2011; 208: 663-675.
43. Dou L, Zheng D, Li J, et al. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression. Oncogene 2011; 31: 507-517.
44. Birks DK, Barton VN, Donson AM, et al. Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer 2011; 56: 211-216.
45. Lin RJ, Lin YC, Chen J, et al. MicroRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010; 70: 7841-7850.
46. De Preter K, Mestdagh P, Vermeulen J, et al. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples. Clin Cancer Res 2011; 17: 7684-7692.
47. Riggi N, Suvà ML, De Vito C, et al. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 2010; 24: 916-932.
48. Forestier, E, Andersen, MK, Autio, K, et al. Cytogenetic patterns in ETV6/RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia: A Nordic series of 245 cases and review of the literature. Genes Chrom Cancer 2007; 46: 440-450.
49. Henson, J, Henson, BJ, Bhattacharjee, S, et al. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chrom Cancer 2009; 48: 569-582.
50. Shi, W, Alajez, NM, Bastianutto, C, et al. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer 2010; 126: 2036-2048.
51. Tovar, V, Alsinet, C, Villanueva, A, et al. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol 2010; 52: 550-559.
52. Nagaraja, AK, Creighton, CJ, Yu, Z, et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 2010; 24: 447-463.